Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
about
The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium.Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.Animal models of colitis-associated carcinogenesis.Knockout of the c-Jun N-terminal Kinase 2 aggravates the development of mild chronic dextran sulfate sodium colitis independently of expression of intestinal cytokines TNFα, TGFB1, and IL-6.Activity of taurolidine gels on ex vivo periodontal biofilm.E-Cadherin Expression in Colonic Mucosa with and Without Fecal Stream
P2860
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
@en
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
@nl
type
label
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
@en
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
@nl
prefLabel
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
@en
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
@nl
P2093
P2860
P1476
Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
@en
P2093
Annette M Müller
Ansgar Michael Chromik
Jan-Michel Otte
Martin Albrecht
Sabrina Rottmann
Thomas Herdegen
Ulrich Mittelkötter
Waldemar Uhl
P2860
P304
P356
10.1080/08941930701598784
P577
2007-09-01T00:00:00Z